Literature DB >> 12204877

Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers' lung.

Terttu Harju1, Riitta Kaarteenaho-Wiik, Ylermi Soini, Raija Sormunen, Vuokko L Kinnula.   

Abstract

Glutathione (GSH) plays a major role in protecting the airways against oxidative stress. The rate-limiting enzyme in de novo GSH synthesis is gamma-glutamylcysteine synthetase (gamma-GCS), which is induced by acute exposure to GSH-depleting cytokines and oxidants, but downregulated by transforming growth factor beta and prolonged oxidant exposure, at least in vitro. Cell-specific expression or regulation of gamma-GCS may play an important role both in the defense against oxidants and in the pathogenesis of oxidant-associated airway diseases. In this study, the localizations of gamma-GCS heavy (gamma-GCS-HS) and light (gamma-GCS-LS) subunits were investigated by immunohistochemistry in 22 patients with chronic obstructive pulmonary disease (COPD), 20 smokers without COPD, and 13 lifelong nonsmokers. The ultrastructural distributions of both gamma-GCS subunits were assessed by immuno-electron microscopy. Both subunits were expressed most prominently in the large airways, and their ultrastructural localization was both cytoplasmic and along the plasma membrane. The expression of gamma-GCS-HS was stronger in the central bronchial epithelium than in the peripheral bronchioli (p = 0.020), or in alveolar macrophages (p = 0.008). The expression of gamma-GCS-HS in the central bronchial epithelium showed a tendency to be higher in nonsmokers compared with all smokers (p = 0.052). Alveolar macrophages of nonsmokers had higher levels of gamma-GCS-HS (p = 0.001) and gamma-GCS-LS (p = 0.001) than did smokers. The expression of gamma-GCS-HS in the central bronchial epithelium was more marked in nonsmokers than in patients with COPD (p = 0.015), the difference between smokers and patients with COPD was not significant. In conclusion, the heavy and light subunits of gamma-GCS are mainly expressed in the large airways. Their tendency to decrease in cigarette smokers may further predispose lung cells to ongoing oxidant stress, which contributes to the progression of lung injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204877     DOI: 10.1164/rccm.2112014

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

1.  Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction.

Authors:  David Adenuga; Samuel Caito; Hongwei Yao; Isaac K Sundar; Jae-Woong Hwang; Sangwoon Chung; Irfan Rahman
Journal:  Biochem Biophys Res Commun       Date:  2010-11-19       Impact factor: 3.575

Review 2.  Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.

Authors:  Hongwei Yao; Irfan Rahman
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-04       Impact factor: 4.219

Review 3.  Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases.

Authors:  V L Kinnula
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

Review 4.  Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review.

Authors:  A R Bentley; P Emrani; P A Cassano
Journal:  Thorax       Date:  2008-06-19       Impact factor: 9.139

Review 5.  Environmental toxicity, redox signaling and lung inflammation: the role of glutathione.

Authors:  Saibal K Biswas; Irfan Rahman
Journal:  Mol Aspects Med       Date:  2008-08-08

Review 6.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

Review 7.  Antioxidant therapeutic advances in COPD.

Authors:  Irfan Rahman
Journal:  Ther Adv Respir Dis       Date:  2008-12       Impact factor: 4.031

8.  Oxidative/Nitrosative stress and the pathobiology of chronic obstructive pulmonary disease.

Authors:  Rajesh Pandey; Mamta Singh; Udita Singhal; Krishna Bihari Gupta; Surendra Kumar Aggarwal
Journal:  J Clin Diagn Res       Date:  2013-03-01

9.  Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.

Authors:  Deepti Malhotra; Rajesh Thimmulappa; Ana Navas-Acien; Andrew Sandford; Mark Elliott; Anju Singh; Linan Chen; Xiaoxi Zhuang; James Hogg; Peter Pare; Rubin M Tuder; Shyam Biswal
Journal:  Am J Respir Crit Care Med       Date:  2008-06-12       Impact factor: 21.405

Review 10.  Antioxidant therapies in COPD.

Authors:  Irfan Rahman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.